Giuliana Grossi

A study found that negative experiences and concern for future children's health drive hemophilia carriers to choose prenatal tests, with cognitive factors playing a role.

A year of research emphasizes the significance of collaboration, standardized approaches, and targeted therapies in rare pulmonary diseases.

The consortium involved in the newborn genomic sequencing initiative consists of a diverse and growing selection of stakeholders.

In hemophilia cases where there is uncertainty, especially when your factor level is near the 50% cutoff, genetic testing becomes important, Ragni says.

While the challenges in affordability and accessibility emphasize the importance of early awareness and interventions, equitable access to the screening itself poses a crucial hindrance.

The American Psychiatric Association (APA) Foundation has launched an initiative to prioritize mental health care.

"We won't be content until this is indeed performed in 98% of babies," Stephen Kingsmore, MD, DSc, explains.

According to new CDC research, 20% of mothers reported mistreatment while receiving maternity care for their youngest child.

Catherine Nester, RN, vice president of physician and patient strategies at Inozyme Pharma, highlights the importance of newborn screening for rare diseases and the impact of the BeginNGS diagnostic tool.

Results reveal living in neighborhoods with very high Childhood Opportunity Index (COI) scores is linked with elevated odds of being up to date on preventive visits and immunizations when compared with those living in neighborhoods with very low COI scores.

Stephen Kingsmore, MD, DSc, shares the exciting advancement of the BeginNGS newborn genomic sequencing program as it approaches the end of phase 2.

Results reveal a clear association between the degree of environmental injustice in a neighborhood and the prevalence of self-reported poor or fair health.

Despite receiving their diagnosis at a younger average age, Hispanic or Latino patients paradoxically have the lowest incidence of recent breast cancer screenings prior to diagnosis.

“Our study suggests that narrowly focusing on hospital volumes and tying that to insurance reimbursement might mask complexities and trade-offs in achieving the goal of optimizing patient outcomes and experiences,” lead co-author Lindsay Sabik, PhD, says.

In this interview, Catherine Nester, RN explains the importance of entering phase 2 of the whole genome sequencing newborn screening program.

The new rule is poised to foster safety, equity, and reduce preventable harm within the hospital setting in historically underserved communities.

BeginNGS aims to enable the prompt identification of potential genetic disease with its newborn screening program.

The BeginNGS program added 23 new founding members to the consortium and expanded to include 31 additional genetic disorders in its second phase screening, totaling 419 treatable genetic disorders.

Even after adjustments, the underlying trends in disparities persisted, underscoring the significance of survival disparities among second primary cancer survivors.

Among 2.5 million adults with opioid use disorder (OUD), only 36% received any substance use treatment, and only 22% received medications for OUD in a recent study.

The data provide promising results, yielding a smoking abstinence rate of 26.4% in the intervention group at 18 months.

"Our research is unique in its attempt to describe a high-need, high-cost patient population who might benefit from increased monitoring or intervention,"Ann Cameron, PhD, says.

An immune-mediated relationship between the brain and skin has been hypothesized in previous studies about psoriasis.